Author

Pierce Ogden

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Synthetic Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 2 Research Focus:protein design· 2 Assay:protein sequence· 2 Approach:benchmark study· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Erik Swanson· 2 shared Supriya RavichandraniD· 2 shared Alena KhmelinskaiaiD· 1 shared Alex Reis· 1 shared Anna U. Macintyre· 1 shared Arash VahdatiD· 1 shared Bhoomika Basu MallikiD· 1 shared Christian DallagoiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Erik Swanson

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Latent generative search unlocks de novo design of untapped biomolecular interactions at scale

Kieran Didi, Danny Reidenbach, Matthew Penner, Supriya Ravichandran, Marshall Case, Mike Nichols, Erik Swanson, Alex Reis, Maggie Prescott, Yue Hong Qian, Dongming Qian, J.S. Yang, Weiji Li, Le Li, Daichi Shonai, , Karsten Kreis

Reward-guided inference-time search over the Proteína-Complexa sequence-structure codesign model yields validated binders across 127 targets, kinases and a free carbohydrate, with codesigned sequences outperforming ProteinMPNN redesign.

bioRxiv · Sep 18, 2026 · PreprintBioengineering✦ In-depth digest

mBER: Controllable de novo antibody design with million-scale experimental screening

Erik Swanson, Michael Nichols, Supriya Ravichandran, Pierce Ogden

The paper introduces mBER, a system for designing antibody-format binders with high experimental success rates, achieving 45% success across 145 targets and 38% binding rates to specific epitopes.

bioRxiv · Sep 26, 2025 · PreprintSynthetic Biology